Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-Time glucose monitor may help type 2 diabetes patients without insulin

NCT ID NCT07298850

Ongoing Symptom relief Sponsor: Kangbuk Samsung Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether wearing a continuous glucose monitor (CGM) and seeing real-time blood sugar readings can help people with type 2 diabetes who don't use insulin improve their glucose control. For one week, participants wear the device without seeing their numbers; the next week, they see their levels and trends. Researchers compare the time spent in a healthy blood sugar range between the two weeks to see if just having the information makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
continuous glucose monitoring (CGM) device
What this could lead to
If it works, this could show that simply viewing real-time glucose readings helps people with type 2 diabetes better manage their blood sugar without needing extra training or medication changes.
What could go wrong
This is a small, early-stage study with only 120 participants and a short two-week monitoring period. The results may not apply to all people with type 2 diabetes, and the improvement might be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTINUOUS GLUCOSE MONITORING TYPE 2 DIABETES

Contacts and locations

Locations

  • Kangbuk Samsung Hospital

    Seoul, Jongro-Ku, 03181, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.